InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,571.75
(
1.09%
)
Post# of 402721
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Dr Jerry

Send PM Follow Ignore
Followers 121
Posts 2016
Boards Moderated 0
Alias Born 11/20/2012

Dr Jerry

Re: None

Tuesday, 08/04/2015 8:20:51 PM

Tuesday, August 04, 2015 8:20:51 PM

Post# of 402721
Kevetrin phase 1 trial reminds me of the multibillion dollar drug for multiple myeloma, Revlimid.

The phase 1 trial went on for almost 2 years because the drug was so well tolerated and MTD took a while to achieve.

All during the phase 1 trial which spanned 2 ASCO meetings investors got impatient and reports of efficacy were revealed surreptitiously along the way.

This is similar to what Leo revealed at ASCO 2015 about an ovarian cancer patient who's splenic metastasis completely disappeared. P21 activation in 50% of patients treated,,,

Today Revlimid is the standard of care for treating myeloma. 5 Billion dollars a year in revenue.

Patience here will be greatly rewarded.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!